tiprankstipranks
Trending News
More News >
Mankind Pharma Ltd. (IN:MANKIND)
:MANKIND
India Market

Mankind Pharma Ltd. (MANKIND) Stock Statistics & Valuation Metrics

Compare
1 Followers

Total Valuation

Mankind Pharma Ltd. has a market cap or net worth of ₹963.41B. The enterprise value is ₹571.37B.
Market Cap₹963.41B
Enterprise Value₹571.37B

Share Statistics

Mankind Pharma Ltd. has 412,728,760 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding412,728,760
Owned by Insiders
Owned by Institutions

Financial Efficiency

Mankind Pharma Ltd.’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 19.17%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)19.17%
Return on Capital Employed (ROCE)0.27
Revenue Per Employee
Profits Per Employee
Employee Count
Asset Turnover0.44
Inventory Turnover1.67

Valuation Ratios

The current PE Ratio of Mankind Pharma Ltd. is 50.08. Mankind Pharma Ltd.’s PEG ratio is 0.71.
PE Ratio50.08
PS Ratio0.00
PB Ratio16.35
Price to Fair Value6.96
Price to FCF67.69
Price to Operating Cash Flow53.26
PEG Ratio0.71

Income Statement

In the last 12 months, Mankind Pharma Ltd. had revenue of 122.07B and earned 19.91B in profits. Earnings per share was 49.17.
Revenue122.07B
Gross Profit87.18B
Operating Income60.26B
Pretax Income25.16B
Net Income19.91B
EBITDA30.18B
Earnings Per Share (EPS)49.17

Cash Flow

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00

Dividends & Yields

Mankind Pharma Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.52
52-Week Price Change7.96%
50-Day Moving Average2.44K
200-Day Moving Average2.52K
Relative Strength Index (RSI)42.80
Average Volume (3m)8.48K

Important Dates

Mankind Pharma Ltd. upcoming earnings date is Jul 30, 2025, Before Open (Confirmed).
Last Earnings DateMay 21, 2025
Next Earnings DateJul 30, 2025
Ex-Dividend Date

Financial Position

Mankind Pharma Ltd. as a current ratio of 1.23, with Debt / Equity ratio of 3.76%
Current Ratio1.23
Quick Ratio0.86
Debt to Market Cap0.09
Net Debt to EBITDA2.64
Interest Coverage Ratio14.03

Taxes

In the past 12 months, Mankind Pharma Ltd. has paid 5.10B in taxes.
Income Tax5.10B
Effective Tax Rate0.20

Enterprise Valuation

Mankind Pharma Ltd. EV to EBITDA ratio is 35.67, with an EV/FCF ratio of 55.13.
EV to Sales8.82
EV to EBITDA35.67
EV to Free Cash Flow55.13
EV to Operating Cash Flow44.61

Balance Sheet

Mankind Pharma Ltd. has ₹22.45B in cash and marketable securities with ₹85.11B in debt, giving a net cash position of ₹62.66B billion.
Cash & Marketable Securities₹22.45B
Total Debt₹85.11B
Net Cash₹62.66B
Net Cash Per Share₹151.82
Tangible Book Value Per Share-₹50.49

Margins

Gross margin is 67.21%, with operating margin of 49.36%, and net profit margin of 16.31%.
Gross Margin67.21%
Operating Margin49.36%
Pretax Margin20.61%
Net Profit Margin16.31%
EBITDA Margin24.72%
EBIT Margin19.63%

Analyst Forecast

The average price target for Mankind Pharma Ltd. is ₹2,150.00, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target₹2,150.00
Price Target Upside-15.12% Downside
Analyst ConsensusModerate Sell
Analyst Count1
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis